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Abstract
Aim The aim of this study was to investigate the micro-
biology of secondary bacterial peritonitis due to appendi-
citis and the appropriateness of current antimicrobial
practice in one institution.
Methods A 14-year retrospective single-centre study of
69 consecutive paediatric patients (age 1–14 years) with
appendicitis-related peritonitis and positive peritoneal
specimen cultures was conducted. Post-operative out-
comes, microbiology and antibiotic susceptibility of peri-
toneal isolates were analysed in all patients.
Results Escherichia coli was identified in 56/69 (81 %)
peritoneal specimens; four isolates were resistant to
amoxicillin–clavulanate, and one other isolate was resistant
to gentamicin. Anaerobes were identified in 37/69 (54 %)
peritoneal specimens; two anaerobic isolates were resistant
to amoxicillin–clavulanate and one isolate was resistant to
metronidazole. Pseudomonas aeruginosa was identified in
4/69 (6 %) peritoneal specimens, and all were susceptible
to gentamicin. Streptococcal species (two Group F strep-
tococci and three b-haemolytic streptococci) were identi-
fied in 5/69 (7 %) specimens, and all were susceptible to
amoxicillin–clavulanate. Combination therapy involving
amoxicillin–clavulanate and aminoglycoside is appropriate
empirical treatment in 68/69 (99 %) patients. Addition of
metronidazole to this regime would provide 100 % initial
empirical coverage. Inadequate initial empiric antibiotic
treatment and the presence of amoxicillin–clavulanate
resistant E. coli were independent predictors of the post-
operative infectious complications observed in 14/69
(20 %) patients.
Conclusion E. coli and mixed anaerobes are the pre-
dominant organisms identified in secondary peritonitis
from appendicitis in children. Inadequate initial empirical
antibiotic and amoxicillin–clavulanate resistant E. coli may
contribute to increased post-operative infectious compli-
cations. This study provides evidence-based information on
choice of combination therapy for paediatric appendicitis-
related bacterial peritonitis.
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Introduction
Peritonitis is an inflammation of the membrane lining the
inside of the abdomen/pelvis and all of the internal organs.
Secondary peritonitis, as opposed to primary peritonitis,
which occurs spontaneously, is the result of some other
disease process [1]. In children, the most common cause of
secondary peritonitis is perforated appendicitis and intra-
abdominal abscess arising from acute appendicitis [1].
Secondary peritonitis in children is usually community
acquired and accounts for prolonged hospitalisation [1, 2].
The aetiology of this disease is predominantly microbial
with organisms from gut flora namely Enterobacteriaceae
(coliforms) and anaerobes as pathogens [1, 3, 4].
Effective antimicrobials currently in use in Europe and
throughout the world are fast losing ground as these
causative pathogens, particularly the Enterobacteriaceae,
acquire resistance to newly introduced antibiotics [5].
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Despite this awareness, studies of secondary peritonitis due
to appendicitis in children are limited [1, 6–9]. Treatment
protocols vary widely and are guided by anti-microbial
resistance patterns [7, 10, 11]. Complete antimicrobial
coverage may be achieved using multiple agents [7, 10,
12–16]. However, targeted antibiotic treatment is prefera-
ble in the interest of decreasing resistance [1, 17–19].
Currently, in Ireland, antibiotic monotherapy (usually
amoxicillin–clavulanate) is recommended for use in the
management of uncomplicated appendicitis. For peritoni-
tis, the recommendation is the use of combination antibi-
otic therapy involving amoxicillin–clavulanate and an
aminoglycoside, gentamicin. In penicillin-sensitive
patients, a combination of gentamicin or cephalosporin and
metronidazole may be effective. The aim of this study was
to investigate the microbiology of secondary bacterial
peritonitis due to appendicitis and the appropriateness of
current antimicrobial practice in one institution.
Methods
A retrospective review of consecutive children (age
between 1 and 14 years) presenting with secondary bac-
terial peritonitis due to appendicitis between January 1995
and December 2008 was conducted in one institution.
Patients
There were 105 children with macroscopic findings of
perforated appendicitis or abscess during appendicectomy
during the study period. 25 (24 %) of these were excluded
because no fluid specimens were sent for microbiological
analysis and 11 (10 %) were further excluded because their
peritoneal fluid specimens did not grow any organism. The
remaining 69 children with perforated appendicitis and
intra-abdominal abscess and who had positive cultures
formed the principal cohort for analysis. It is important to
note that subjects with simple acute non-perforated
appendicitis or gangrenous appendicitis (macroscopic)
without evidence of perforation were not part of this study.
Specimen culture
Peritoneal fluid specimens in the cohort were sent directly
to the laboratory or kept at 4 C until the next day if they
were collected after hours. For aerobic culture, the fluid
specimens were inoculated onto Columbia blood agar and
MacConkey agar without salt. The plates were incubated at
37 C in air atmosphere and were examined 24 and 48 h
after incubation.
For anaerobic culture, the fluid specimens were plated
onto Columbia blood agar, neomycin blood agar, and
nalidixic acid agar and each plated agar further impreg-
nated with metronidazole discs so as to guide sensitivity
analysis. All plates were incubated in an anaerobic gas jar
with O2 levels \1 % and CO2 levels between 9 and 13 %
and examined for growth at 24, 48, 96 and 120 h after
incubation.
All aerobic isolates were fully identified. Specimens with
anaerobic isolates having more than one anaerobe identified
were classified as mixed anaerobe. Sensitivity analysis was
conducted with the aid of a rapid and automated VITEC-2
compact system (Biome´rieux, France). This system has
been in place since 2005. The Clinical and Laboratory
Standards Institute dilution method was used for sensitivity
testing between 1998 and 2005, and before this time, the
Stokes’ method of sensitivity testing was used.
Data collection
Data recorded included: demographic data, microbiological
data (peritoneal fluid specimens and susceptibility to antibi-
otics), antibiotic management (initial therapy, changes in
therapy, and duration of treatment) and outcomes. Infectious
complications were defined as those occurring within 30 days
of surgery and included intra-abdominal abscess and wound
infection. The intra-abdominal abscesses were confirmed by
imaging and microbiological samples. Wound infection was
confirmed clinically and by microbiological samples. Patients
who received oral doses of antibiotics in the community
within a 1-week period before hospital admission were
recorded. Adequate empirical antibiotic treatment was
defined as resolution of disease with initial or step-down
antibiotic treatment after primary surgery. Empirical antibi-
otic treatment was inadequate if the infection was non-
resolving and additional antibiotics were commenced post-
operatively based on intraperitoneal fluid culture results.
Data analysis
Statistical analysis was conducted using the STATA 11.0
(Stata, College Station, TX) software. Continuous data were
expressed as median and percentiles (25–75 %) and analysed
by a Mann–Whitney U test. Data expressed by percentage of
children were analysed by Chi-square and Fisher’s exact test
as appropriate. Differences were considered statistically sig-
nificant at the 5 % level (P \ 0.05). For subgroup analysis,
data was classified into two periods: 1995–2002 (36 patients)
and 2003–2008 (33 patients). This division was necessary to
identify trends, if any, in the use of antibiotics.
Like previous studies, potential variables that may be
associated with a higher risk of post-operative infection
and hospitalisation in the cohort of patients with appendi-
citis-related community acquired peritonitis were exam-
ined [1, 2]. Significant risk factors identified after
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univariate testing (defined by P \ 0.2) were further tested
in a multivariate logistic regression model [1, 2]. Variables
associated with P \ 0.05 after multivariate analysis were
considered independent factors of risk. Odds ratios and
their 95 % confidence intervals were calculated.
Results
Patients
The 69 children with secondary appendicitis-related bac-
terial peritonitis included 31 females. The median age at
the time of surgery was 8 (5–11) years.
Clinical outcome
56/69 (81 %) patients had localised peritonitis and the
remaining 13/69 (19 %) had generalised peritonitis. 68/69
(98.5 %) patients had open appendicectomy. Two children
underwent a ‘second look’ operation in both cases for
prolonged ileus in the post-operative period. 14/69 (20 %)
patients had infective complications. There were 18
infective complications recorded in the 14 patients (9 intra-
abdominal collections, 5 superficial wound infections, 2
deep wound infections/dehiscence and 2 chest infections).
The median length of stay in hospital was 6 (5–8) days.
Microbiology
The microorganisms identified in the peritoneal specimens
of the 69 patients are shown in Table 1. Single isolates
were identified in 31/69 patients (45 %), and multiple
isolates were identified in the other 38 (55 %) patients.
Escherichia coli was identified in 56/69 (81 %) specimens;
Four of these isolates were resistant to amoxicillin–cla-
vulanate and only one of the E. coli strains was resistant to
the aminoglycoside, gentamicin. There was no isolates of
extended spectrum beta lactamases or carbapenem-resis-
tant Enterobacteriaceae identified in any of the specimens,
but these may be important in the future. Streptococcal
species (two Group F streptococci and three b-haemolytic
streptococci) were identified in 5/69 (7 %) specimens. All
the streptococcal species were sensitive to amoxicillin–
clavulanate. Pseudomonas aeruginosa was identified in
4/69 (6 %) specimens; all were sensitive to gentamicin.
Mixed anaerobes were identified in 37/69 (54 %) speci-
mens; two anaerobic isolates were resistant to amoxicillin–
clavulanate and one isolate was resistant to metronidazole.
A resistant-sensitive ‘‘synergism’’ was found between
metronidazole and gentamicin for anaerobes and coliforms.
Simply put, we noted sensitivity to gentamicin in one case
of metronidazole-resistant anaerobes and sensitivity to
metronidazole was documented in one case of gentamicin-
resistant coliform.
Antibiotic treatment
All patients received antibiotics pre-operatively. Median
duration of intravenous antibiotic treatment was 4
(3–6) days. 9/69 (13 %) patients had received oral antibiotics
in the community prior to presentation to hospital (Amoxi-
cillin in six cases, amoxicillin–clavulanate in two cases and
erythromycin in one case). For initial in-hospital treatment,
25/69 (36 %) patients received triple drug therapy (amoxi-
cillin–clavulanate/cephalosporin ? metronidazole ? ami-
noglycoside) and the other 44/69 (64 %) patients received a
double combination of amoxicillin–clavulanate/cephalo-
sporin and metronidazole. We were unable to assess exactly
what guided these decisions. Antibiotic treatment changed
based on findings at operation without peritoneal specimen
culture and sensitivity results in 10/69 (14 %) children.
Antibiotic treatment was considered inadequate and modi-
fied in accordance with culture results in 4/69 (6 %) chil-
dren. 13/69 (19 %) patients had de-escalation of treatment
following laboratory susceptibility results.
Use of cephalosporin versus amoxicillin–clavulanate
combination therapy
Over time, cephalosporin combination therapy became less
frequently used as initial treatment in the treatment of sec-
ondary community acquired peritonitis. They accounted for
86 % of the empirical treatment from 1995 to 2002 and 67 %
of empirical treatment from 2003 to 2008. Amoxicillin–
clavulanate combination therapy became increasingly used
in the treatment of appendicitis-related peritonitis as the use
of cephalosporins declined. In 12 out of the 13 patients who
had de-escalation of treatment following laboratory sus-
ceptibility results, this involved stopping a cephalosporin
and commencing amoxicillin–clavulanate instead.





Escherichia coli 56 (81)
Other Enterobacteriaceae 5 (7)
Pseudomonas aeruginosa 4 (6)
Gram positive
Group F streptococci 2 (3)
B-haemolytic streptococci 3 (4)
Anaerobes 37 (54)
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The antibiotic susceptibility data suggested that combi-
nation therapy involving amoxicillin–clavulanate and
gentamicin would have been appropriate empirical treat-
ment in 68/69 (99 %) patients. Addition of metronidazole
to this regime would have provided 100 % initial empirical
coverage.
Risk factors for post-operative infection and hospital
stay
Significant variables associated with increased risk of post-
operative infection are presented in Table 2. Results of
testing of variables that may be associated with prolonged
hospitalisation are presented in Table 3. Independent risk
factors for post-operative infectious complications identi-
fied on multivariate analysis were: isolation of E. coli
resistant to amoxicillin–clavulanate in the peritoneal fluid
specimen (OR, 21.88 [1.7–277.2]; P = 0.017) and inade-
quate initial antibiotic therapy (OR, 18.37 [1.1–321.0];
P = 0.046). Female gender (OR, 3.11 [0.7–14.4]; P =
0.146), isolation of P. aeruginosa (OR, 1.55 [0.1–2.2];
P = 0.7697) or finding of appendicular abscess (OR, 2.68
[0.6–11.8]; P = 0.193) did not reach statistical significance
on multivariate analysis.
We did not identify any significant risk factor for prolonged
hospitalisation more than 7 days in patients with appendicitis-
related peritonitis on multivariate analysis. We, however,
found that the duration of hospitalisation was directly related
to the duration of intravenous treatment required to treat each
case based on the severity and clinical response.
Discussion
In the peritoneal samples of 69 children with secondary
peritonitis from appendicitis, E. coli was identified in 56/69
(81 %) peritoneal specimens; four isolates were resistant to
amoxicillin–clavulanate, and one other isolate was resistant
to gentamicin. Anaerobes were identified in 37/69 (54 %)
Table 2 Univariate analysis of factors associated with a risk of post-









Age (years), median (25th–75th) 8.5
(5–12)
8 (5–11) 0.512
Sex ratio F/M, n 4/10 27/28 0.168*
Generalised peritonitis, n (%) 3 (21) 10 (18) 0.781
Intra-abdominal abscess, n (%) 6 (43) 14 (25) 0.200*
Use of cefuroxime–metronidazole,
n (%)
9 (64) 36 (65) 0.935
Use of amoxicillin–clavulanate
combination, n (%)
4 (29) 13 (24) 0.702
Bacteriology, n (%)
Monomicrobial 6 (43) 27 (49) 0.677
Polymicrobial 8 (57) 28 (51)
Escherichia coli, n (%) 11 (79) 45 (82) 0.781
Anaerobic microorganisms, n (%) 8 (57) 29 (52) 0.767
Pseudomonas aeruginosa, n (%) 2 (14) 2 (3) 0.128*
Other Enterobacteriaceae, n (%) 2 (14) 3 (5) 0.255
E. coli strain resistant to
amoxicillin–clavulanate, n (%)
3 (21) 1 (2) 0.005*
Streptococci spp (two Group
F ? three b-haemolytic
streptococci), n (%)
0 (0) 5 (9) 0.241
Pre-hospital antibiotic treatment 7 (13) 2 (14) 0.872
Inadequate initial treatment, n (%) 3 (21) 1 (2) 0.005*
Comparison by X2, Fisher exact test, Mann and Whitney test as
appropriate
* Variables with a P value \0.2 were tested in a multivariate logistic
regression model
Table 3 Univariate analysis of factors associated with a risk of







Age (years), median (25th–75th) 8 (4–10) 9 (5–11) 0.442
Sex ratio F/M, n 7/15 24/23 0.134*
Generalised peritonitis, n (%) 6 (27) 7 (15) 0.220
Intra-abdominal abscess, n (%) 5 (23) 15 (32) 0.433
Use of cefuroxime–metronidazole,
n (%)
15 (68) 30 (64) 0.724
Use of amoxicillin–clavulanate
combination, n (%)
6 (27) 11 (23) 0.728
Bacteriology, n (%)
Monomicrobial 7 (32) 21 (45) 0.069*
Polymicrobial 15 (68) 26 (55)
Escherichia coli, n (%) 19 (86) 37 (79) 0.449
Anaerobic microorganisms, n (%) 15 (68) 22 (47) 0.097*
Pseudomonas aeruginosa, n (%) 1 (5) 3 (6) 0.761
Other Enterobacteriaceae, n (%) 2 (9) 3 (6) 0.686
E.coli strain resistant to
amoxicillin–clavulanate, n (%)
2 (9) 2 (4) 0.423
Streptococci spp (two Group
F ? three b-haemolytic
streptococci), n (%)
0 (0) 5 (11) 0.112*
Pre-hospital antibiotic treatment 7 (15) 2 (9) 0.505
Inadequate initial treatment, n (%) 2 (9) 2 (4) 0.423





Comparison by X2, Fisher exact test, Mann and Whitney test as
appropriate
* Variables with a P value\0.2 were tested in a multivariate logistic
regression model
a Included variable is a surrogate for disease severity and not a risk
factor per se
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peritoneal specimens; two anaerobic isolates were resistant
to amoxicillin–clavulanate and one isolate was resistant to
metronidazole. P. aeruginosa was identified in 4/69 (6 %)
peritoneal specimens, and all were susceptible to genta-
micin. Streptococcal species (two Group F streptococci and
three b-haemolytic streptococci) were identified in 5/69
(7 %) specimens, and all were susceptible to amoxicillin–
clavulanate. Post-operative infectious complications
occurred in 14/69 (20 %) patients and predictors of
increased post-operative complications were identified.
The rationale for use of combination therapy in the treat-
ment of secondary peritonitis was also presented.
The current study may differ from previous studies due
to the homogeneity of the group studied but striking other
similarities need to be underpinned. E. coli and Bacteroides
fragilis (anaerobe) are the main pathogens involved in
paediatric appendicitis-related peritonitis [1, 8, 9, 20].
Isolation of E. coli resistant to amoxicillin–clavulanate
may be associated with post-operative peritonitis [1].
Appropriate initial antimicrobial therapy may predict suc-
cessful treatment of peritonitis [21]. Isolation of P. aeru-
ginosa in peritoneal specimens may be associated with
post-appendicectomy surgical infections in the absence of
appropriate primary antibiotics [4, 22].
Dumont et al. [1] evaluated microbiology and antimi-
crobial susceptibility of peritoneal isolates in children who
underwent surgery for community acquired peritonitis in a
single surgical centre. The study’s sample size was similar
to that of this study and included only 70 patients: 69
children with peritonitis from appendicitis and 1 from
perforation of the small intestine. They found that E. coli
and anaerobes were the main pathogens involved in pae-
diatric community acquired peritonitis. They found a
10.4 % resistance rate of coliforms to amoxicillin–clavul-
anate. Similar to the current study, they showed that the
presence of E. coli resistant to amoxicillin–clavulanate was
an independent risk factor associated with post-operative
peritonitis.
Krobot et al. [21], in a multicentre study of 162 patients
with perforated appendicitis, found that appropriateness of
initial parenteral antibiotic therapy was a predictor of
clinical success and length of stay. Similarly, they dem-
onstrated a high risk of post-operative infections in patients
with inadequate empirical treatment.
Two studies in the paediatric population had found a
positive correlation between isolation of P. aeruginosa in
peritoneal specimens and post-appendicectomy surgical
infections [4, 22]. Chen et al. [4] isolated P. aeruginosa in
18/117 (15 %) fluid specimens of patients with appendicitis
and demonstrated a positive correlation between isolation
of P. aeruginosa and surgical site infections. They found
that P. aeruginosa was frequently not covered by chosen
prophylactic antibiotics. 7/18 (39 %) P. aeruginosa in that
study was resistant to cefuroxime, and they identified
pseudomonas in peritoneal specimens of 5/8 (63 %)
patients who later developed surgical site infections. Yellin
et al. [22], also reported a high rate of infectious compli-
cations in patients with appendicitis from whom P. aeru-
ginosa were isolated. Compared to these two studies, this
study identified P. aeruginosa in 4/69 (6 %) specimens and
all 4 isolates were sensitive to gentamicin. We found that
the four patients with P. aeruginosa in their peritoneal
specimens had been on cefuroxime and metronidazole as
empirical treatment; two of these patients subsequently
developed significant intra-abdominal infection and
required switch to piperacillin–tazobactam and gentamicin
following drainage procedures.
Conflicting data with respect to the role of P. aeruginosa
in the outcome of peritonitis may be explained by the lack
of appropriate antibiotics in the primary treatment proto-
cols. The summary of the data is that addition of an ami-
noglycoside is paramount when considering treatment for
appendicitis-related peritonitis, and that inadequate initial
empirical treatment may lead to post-operative infectious
complications [1, 23]. Pseudomonas species are also
inherently resistant to amoxicillin–clavulanate, and post-
operative infections might develop if this antibiotic were to
be used alone in the treatment of associated peritonitis.
Knowing the microbial and antibiotic resistance profile
is critical in an attempt to provide the best empirical
antibiotic treatment for secondary peritonitis arising from
appendicitis in children [1]. There is no single empirical
antibiotic known to reduce post-appendicectomy infectious
complications in patients with complicated appendicitis [3,
8, 14, 21, 24]. The current local policies do not favour the
use of cephalosporins for the treatment of infections. We
found evidence to promote the continued use of amoxi-
cillin–clavulanate and aminoglycoside, gentamicin for the
treatment of secondary peritonitis due to appendicitis in
children. We showed that adding amoxicillin–clavulanate
to the combination of metronidazole and gentamicin as
initial empirical treatment provided 100 % coverage of
resistant organisms. The use of only amoxicillin–clavula-
nate and gentamicin was appropriate in 98.5 % of cases.
With respect to the duration of antibiotics, the median
duration of intravenous antibiotic treatment was 4 days.
Patients with more severe disease required at least 5 days
of intravenous antibiotics and this factor contributed to
prolonged hospitalisation [7 days in the cohort. In the
experience of the authors, the antibiotic susceptibility
reports may recommend the continuation of gentamicin
which is only available intravenously. We think initial
treatment in the setting of appendicitis-related peritonitis
using triple antibiotic combination therapy (amoxicillin–
clavulanate, metronidazole and gentamicin) is appropriate
while awaiting definitive culture and sensitivity results.
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This may help reduce the incidence of post-operative
infectious complications associated with amoxicillin-
resistant E. coli in appendicitis-related peritonitis. In
addition, other factors such as attention to basic infection
control strategies, the surgeon’s experience and technique,
the duration of the procedure, hospital and operating room
environment, instrument sterilisation techniques, pre-
operative preparation and management of any underlying
medical condition of the patient should also be considered
[24]. Antibiotic treatment should of course be narrowed
once sensitivity results become available. In this study,
13/69 (19 %) patients had de-escalation of treatment fol-
lowing laboratory susceptibility results.
Retrospective, single-centre studies may limit generali-
sations. Further, susceptibility to cephalosporins was not
routinely available due to local antimicrobial management
policy and clinicians did not adhere to a strict antimicrobial
protocol. However, the study findings are in line with
previously documented work in this area. We feel such
findings may help in the formation of consensus guidelines/
design of future trials. Patients in this study were screened
for risk factors for post-operative infection and length of
stay. Independent risk factors for post-operative infection
were inadequate initial empirical antibiotic treatment and
the presence of amoxicillin-resistant E. coli. Rationale for
adding other empirical antibiotics to amoxicillin–clavula-
nate in the treatment of appendicitis-related peritonitis in
children has been presented.
Conclusion
Perforation of the appendix inevitably leads to significant
bacterial contamination and morbidity. E.coli and mixed
anaerobes are the predominant organisms involved in the
resulting peritonitis. No single antimicrobial treatment is
effective and antibiotic resistance is common. Inadequate
initial empirical antibiotic and amoxicillin–clavulanate
resistant E. coli may contribute to increased post-operative
infectious complications. Based on the clinical data pre-
sented, a triple antibiotic combination of amoxicillin–cla-
vulanate, gentamicin and metronidazole is reasonable
empiric basis for treatment of appendicitis-related
peritonitis.
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